Found: 14
Select item for more details and to access through your institution.
Outcomes of male patients with HR+/HER2– advanced breast cancer receiving palbociclib in the real-world POLARIS study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 463, doi. 10.1007/s10549-023-07145-1
- By:
- Publication type:
- Article
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16<sup>INK4a</sup>.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa082
- By:
- Publication type:
- Article
Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 6, p. 1474, doi. 10.1002/cam4.4566
- By:
- Publication type:
- Article
Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 17, p. 2945, doi. 10.1002/cncr.32175
- By:
- Publication type:
- Article
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Potentially inappropriate medication use in older patients with breast and colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Frequency of mesenchymal-epithelial transition factor gene (MET) and the catalytic subunit of phosphoinositide-3-kinase (PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Frequency of mesenchymal-epithelial transition factor gene ( MET) and the catalytic subunit of phosphoinositide-3-kinase ( PIK3CA) copy number elevation and correlation with outcome in patients with early stage breast cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 1, p. 7, doi. 10.1002/cncr.27608
- By:
- Publication type:
- Article
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00473-3
- By:
- Publication type:
- Article
Patient‐Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 762, doi. 10.1634/theoncologist.2018-0590
- By:
- Publication type:
- Article
Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-A National Cancer Database analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 957, doi. 10.1002/cncr.33329
- By:
- Publication type:
- Article
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
- Published in:
- JMIR Cancer, 2022, v. 8, n. 2, p. 1, doi. 10.2196/33859
- By:
- Publication type:
- Article